Wms Partners, LLC Supernus Pharmaceuticals, Inc. Transaction History

Wms Partners, LLC

  • $1.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$14.45 - $24.69 $1.06 Million - $1.81 Million
-73,208 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$19.93 - $29.13 $398 - $582
20 Added 0.03%
73,208 $1.74 Million
Q1 2019

May 13, 2019
BUY
$32.77 - $41.99 $2.4 Million - $3.07 Million
73,188 New
73,188 $2.57 Million

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.93B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Wms Partners, LLC Portfolio

Follow Wms Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email